Laura Perrelle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-9029 |
Blake Collier Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-9029 |
Osei Nti Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-9029 Fax: 765-653-6276 |
Lynne Michelle Lynch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-1606 |
Amanda Susan Lackey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-9020 |
Mr. Greg Allen Selvia Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1542 S Bloomington St, Greencastle, IN 46135 Phone: 765-655-2634 Fax: 765-655-2636 |
Dr. Brian Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-6575 Fax: 765-653-4880 |
Dr. Robin Bryant, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-1606 Fax: 765-653-1859 |
Mrs. Jody Lynn Hinkle Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-1606 Fax: 765-653-1859 |
Audrey Tepe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-9029 |
Lydia M Aspatore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Indianapolis Rd, Greencastle, IN 46135 Phone: 765-653-1606 |
News Archive
With the reopening of flights during the summer holiday season in Europe, many countries have started to see an increase in COVID-19 infections.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.
In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.
› Verified 9 days ago